Visual Outcomes and Patient Satisfaction With a New Trifocal, Toric Intraocular Lens.

PURPOSE: Describe visual outcomes, rotational stability, and patient experience with a new, trifocal, toric intraocular lens (IOL), CNWTTx (Alcon, Fort Worth, TX.).

PATIENTS AND

METHODS

Prospective, cohort study in a private practice in Salt Lake City, UT. Patients 45 years and older with visually significant cataracts, bilateral regular corneal astigmatism requiring a T3-T6 IOL power lens, no other significant eye disease undergoing sequential cataract surgery with Clareon PanOptix Toric IOL (CNWTTx) followed for 3 months postoperatively. Primary endpoints: monocular corrected distance visual acuity (CDVA), distance-corrected intermediate visual acuity (DCIVA), and distance-corrected near visual acuity (DCNVA). Secondary endpoints: rotational position of the IOL and a patient satisfaction survey.

RESULTS

Twenty-five patients were recruited into the study and 22 received bilateral Clareon PanOptix Toric IOLs. At 3-month postoperative visit, visions were monocular mean CDVA of LogMAR (LM) 0.004, mean DCIVA of LM 0.110, and mean DCNVA of LM 0.056. 89% of patients had 0.5 diopters or less of residual astigmatism. Mean lens rotation was 1.67° at 1 month, and no lenses had rotated more than 5°. The majority of patients "never" used glasses at near (88%), at arm's length (100%) and at a distance (92%). In spite of 25% of patients noting photopic phenomena either "most of the time" or "always," a majority (88%) of patients were either "satisfied" or "very satisfied" with their vision, and 92% would have the same lens implanted again.

CONCLUSION

The CNWTTx lens results in excellent visual acuities at distance, intermediate, and near, leading to high rates of spectacle independence. The lens is rotationally stable, and patients are subjectively satisfied with their visual outcomes.